CA-GLOBALLOGIC-INC.
GlobalLogic Inc., a Hitachi Group company and Digital Engineering leader, announced today that it has been named an overall Leader in the Zinnov Zones for ER&D Services 2022 Ratings. The report provides a 360-degree assessment of engineering research and development (ER&D) service providers, identifying their prowess and scalability across key markets and technologies. It is leveraged by company decision makers seeking to identify vetted service providers to support a wide range of engineering projects. Such resources are increasingly more important as investment in digital transformation rises rapidly across all industries to satisfy a growing demand for intelligent, connected, and data-driven experiences for consumers and company employees alike.
Zinnov is a global management consulting and strategy advisory firm with 20+ years of experience. As part of its annual ER&D Services Zinnov Zones ratings exercise, the company evaluates more than 50 global service providers across multiple verticals, micro-verticals, and geographies. GlobalLogic’s earned position as an overall leader indicates the digital engineering firm has demonstrated itself to be an Established, Expansive company when compared to its peers—labels specifically measuring:
- Established: proven specialization; R&D practice maturity (depth and maturity of services); innovation and IP; ecosystem linkages
- Expansive: scale and scalability; number of verticals serviced; client spread/diversification
Validating its overall leadership recognition, GlobalLogic was rated in the leadership zone for the following verticals and technologies:
- Automotive
- Consumer Software
- Data & AI Engineering
- Enterprise Software
- Experience Engineering
- Telecommunications
- Telehealth
The 2022 edition of the Zones ratings marks GlobalLogic’s seventh year earning a spot in the ER&D Services Ratings’ general leader quadrant, having first placed there in 2016. While GlobalLogic first moved to an overall leadership position three years ago, it has since moved up in its rating and earned higher leadership zone positions in several sub-categories listed above.
“The recognition received in the Zinnov Zones evaluation is a direct testament to the ingenuity, commitment, and skills displayed by our team members around the world,” said Arya Barirani, Chief Marketing Officer, GlobalLogic. “From our perspective, this rating acknowledges our continued ability to deepen our foothold in a wide variety of markets. It also acknowledges our dedication to broadening our experience in technologies that drive next- gen digital transformations. These investments in our people, training, and facilities are all designed to help us better serve our customers.”
Sidhant Rastogi, Managing Partner, Zinnov, said, “GlobalLogic’s intense focus on building new-age technology capabilities, combined with its digital accelerators and its self-contained innovation labs, has helped the firm drive high value transformation for its customers. GlobalLogic continues to strengthen its digital core through strategic acquisitions like Fortech, which has enabled it to expand its portfolio of offerings across technologies and geographies. A well-articulated growth strategy and a data-driven approach across its wide-spectrum of Digital Engineering Services offerings has helped GlobalLogic firmly anchor its leadership position in the 2022 Zinnov Zones ER&D ratings.”
The 2022 ER&D Services Ratings report as well as prior year reports can be found here: https://zinnovzones.com/ratings/e-r-and-d-services/overall/2022.
About Zinnov
Founded in 2002, Zinnov is a global management consulting and strategy advisory firm with a presence in New York, Santa Clara, Seattle, Houston, Bangalore, Gurgaon, Paris, and Pune. With a team of experienced consultants, subject matter experts, and research professionals, Zinnov has partnered with Global Enterprises, Fortune 2000 companies, Global System Integrators, and Private Equity firms across their value creation journeys to develop actionable insights – across revenue, talent, innovation, scale, and optimization. For more information, visit Zinnov.
About GlobalLogic
GlobalLogic (www.globallogic.com) is a leader in digital engineering. We help brands across the globe design and build innovative products, platforms, and digital experiences for the modern world. By integrating experience design, complex engineering, and data expertise – we help our clients imagine what’s possible and accelerate their transition into tomorrow’s digital businesses. Headquartered in Silicon Valley, GlobalLogic operates design studios and engineering centers around the world, extending our deep expertise to customers in the automotive, communications, financial services, healthcare and life sciences, manufacturing, media and entertainment, semiconductor, and technology industries. GlobalLogic is a Hitachi Group Company operating under Hitachi, Ltd. (TSE: 6501), which contributes to a sustainable society with a higher quality of life by driving innovation through data and technology as the Social Innovation Business.
GlobalLogic is a trademark of GlobalLogic. All other brands, products or service names are or may be trademarks or service marks of their respective owners.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230111005241/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
Lattice Wins 2025 Global Semiconductor Alliance Award6.12.2025 00:49:00 CET | Press release
‒ Named Most Respected Public Semiconductor Company Achieving $100 Million to $500 Million in Annual Sales ‒ Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it was selected as ‘Most Respected Public Semiconductor Company’ at the 2025 Global Semiconductor Alliance (GSA) Awards. The GSA awards recognize companies that have demonstrated excellence through their success, vision, strategy, and future opportunities in the industry as determined by votes from GSA members. “We are honored to be recognized by the Global Semiconductor Alliance and our peers as one of 2025’s most respected public semiconductor companies. This recognition reflects the dedication of the Lattice team and the trust of our customers, partners, suppliers, and investors. Looking ahead, we remain laser-focused on driving innovation and strengthening our role as the trusted low power programmable leader for semiconductor and system solutions,” said Ford Tamer, Chief Executive
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom